A Pilot Trial of Chinese Medicine for Patients With Dialytic Hypotension

Starting soon · Phase 2/Phase 3

Conditions studied: End Stage Renal Disease on Dialysis, Intradialytic Hypotension

In brief

To evaluate the epidemiological status of traditional Chinese Medicine (TCM) constitution in patients with dialytic hypotension, and design a clinical study based on a Zheng-based herbal formulation to evaluate the clinical efficacy and safety of TCM

Key facts

Study ID

NCT07425262

Run by

Chang Gung Memorial Hospital

People needed

100

Starts

2026-02-02

Expected to finish

2028-02-01

Last updated by the study team

2026-02-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Maintenance bicarbonate hemodialysis (HD) for more than 1 year, three times a week 3.5 to 4.5 h HD schedule.
• Have experienced more than 30% episodes of IDH (defined as a systolic BP<90 mmHg on dialysis or requirement for clinical intervention) during the exposure assessment period (months 1-3) of this study
• Cognitive ability to give written informed consent.

You may not qualify if…

• Allergic history to Chinese herbal medicine
• Systemic diseases such as coagulation disorders, malignancy, liver diseases and cardiovascular diseases.
• Estimated survival time < 1 year.
• Mental illness.
• Participate in other clinical trials.

Where it is running

• Chang Gung Memorial Hospital in Kaohsiung branch — Kaohsiung City, Taiwan

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.